Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Wilson Tang, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00561483
First received: November 20, 2007
Last updated: January 5, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)